GEORGE BAKER: Open Payments
NPI 1386232601 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,016 in 100 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $384 · 2025 $2,016
Food & beverage: $1,879Education: $137
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 24 | $542 |
| GENZYME CORPORATION | 17 | $362 |
| Regeneron Healthcare Solutions, Inc. | 14 | $345 |
| GlaxoSmithKline, LLC. | 20 | $343 |
| Amgen Inc. | 16 | $234 |
| Insmed, Inc. | 4 | $65 |
| SANOFI-AVENTIS U.S. LLC | 1 | $57 |
| Viatris Specialty LLC | 2 | $35 |
| Genentech USA, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
Products named: DUPIXENT, TEZSPIRE, NUCALA, BREZTRI, AIRSUPRA, TRELEGY ELLIPTA, FASENRA, Arikayce.
Industry payments across OH — which companies pay providers there.
